000			01696 a2200457 4500
005			20250516105128.0
264		0	_c20130523
008			201305s 0 0 eng d
022			_a1563-258X
024	7		_a10.1007/s10354-012-0131-y _2doi
040			_aNLM _beng _cNLM
100	1		_aMalle, Philipp
245	0	0	_aFDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours. _h[electronic resource]
260			_bWiener medizinische Wochenschrift (1946) _cOct 2012
300			_a423-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzamides _xtherapeutic use
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aFluorodeoxyglucose F18
650	0	4	_aGastrointestinal Stromal Tumors _xdiagnostic imaging
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aMolecular Targeted Therapy _xmethods
650	0	4	_aMultimodal Imaging _xmethods
650	0	4	_aNeoplasm Recurrence, Local _xdiagnostic imaging
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPositron-Emission Tomography _xmethods
650	0	4	_aPrognosis
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aSensitivity and Specificity
650	0	4	_aSunitinib
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aTreatment Outcome
700	1		_aSorschag, Manfred
700	1		_aGallowitsch, Hans-Jürgen
773	0		_tWiener medizinische Wochenschrift (1946) _gvol. 162 _gno. 19-20 _gp. 423-9
856	4	0	_uhttps://doi.org/10.1007/s10354-012-0131-y _zAvailable from publisher's website
999			_c22022605 _d22022605